Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
Clinical trial NCT03628209 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03628209
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-03
- Primary completion
- 2024-12-29
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.